Extensive lymph node dissection and overall survival in colon cancer: A systematic review and meta-analysis.

T Tirath Patel (Trinity Medical Sciences University School of Medicine, Rishibi, Saint Vincent and the Grenadines) J Jabez David John (Malla Reddy Institute of Medical Sciences, Hyderabad, India) F Fathimathul Henna (Dubai medical college for girls, Dubai, United Arab Emirates) M Mohammad Moayad Ahmad Alghaniem (School of Medicine, The University of Jordan, Amman, Jordan) A Abdallah Abunamoos (School of Medicine, The University of Jordan, Amman, Jordan) S Shamikha Cheema (King Edward Medical University, Lahore, Pakistan) S S.M Washaqul Arfin (Ziauddin University, Karachi, Pakistan) A Ayeza Nawaz (King Edward Medical University, Lahore , Pakistan) P Pragnesh Kalyandrug (Trinity Medical Sciences University School of Medicine, Ribishi, Saint Vincent and the Grenadines) N Nana Sardarova (Henry Ford Health System, Warren, MI) M Mohammed Barawi (Henry Ford St John Hospital, Detroit, MI) K Kelly Manahan (Trinity Medical Sciences University School of Medicine, Ribishi, Saint Vincent and the Grenadines) J John Geisler (Trinity Medical Sciences University School of Medicine, Ribishi, Saint Vincent and the Grenadines)

Abstract

e15662 Background: Colon cancer remains a leading cause of cancer-related mortality, with surgical resection and lymph node dissection (LND) being key to recovery treatment. Extensive lymph node dissection (ELND) in enhancing overall survival (OS) remains a subject of ongoing debate, as the evidence regarding its benefits versus associated risks is mixed or inconclusive. This meta-analysis aims to evaluate whether ELND improves OS compared to standard lymph node dissection (SLND) in patients with colon cancer while assessing its impact on perioperative outcomes and lymph node retrieval. Methods: This Systematic Review and Meta-Analysis followed the PRISMA guidelines for evaluating the effectiveness of ELND, which analyzed seven articles containing 3,843 patients diagnosed with primarily local-stage (I-III) colon cancer, which met the inclusion criteria after screening 2797 articles, procured from a rigorous search strategy across bibliographic databases of PubMed, Medline, Pubmed Central, Scopus, Web of Science, and Embase until November 2024. Data analysis was performed using RevMan 5.4 software, which facilitated the computation of risk ratios, mean differences, and 95% confidence intervals (CIs). The assessment of heterogeneity was conducted using I² statistics, while the evaluation of publication bias was carried out through the application of funnel plots. Results: ELND showcased significantly better overall survival rates than SLND with an RR of 0.34; 95% CI: 0.17–0.68; p = 0.002 with no observed heterogeneity (I2 = 0%). However, intraoperative complications between ELND and SLND were similar (RR: 0.90; 95% CI: 0.68–1.19; p = 0.45), although with substantial heterogeneity (I2 = 61%). As expected, given the nature of extensive dissection involved in ELND, it is expected to retrieve more lymph nodes, and statistically, there is an average difference of 10 nodes between the approaches (MD: 10.0; 95% CI: 0.10–10.0; p < 0.0001). However, this outcome exhibited significant heterogeneity (I2 = 100%), likely due to the variations in surgical technique and the definitions of "extensive" dissection in each study included in the analysis. The survival benefit could be attributed to a more thorough removal of Lymph nodes, leading to improved disease staging and subsequent risk assessment and treatment planning. Conclusions: ELND provides promising oncological advantages through improved OS and enhanced staging accuracy without any difference in intraoperative complications. These findings suggest ELND is a valuable technique in colon cancer surgery, specifically for local-stage disease. Further research can focus on having a standardized definition of "extensive dissection" and further validate the study results.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (13)

T

Tirath Patel

Trinity Medical Sciences University School of Medicine, Rishibi, Saint Vincent and the Grenadines

J

Jabez David John

Malla Reddy Institute of Medical Sciences, Hyderabad, India

F

Fathimathul Henna

Dubai medical college for girls, Dubai, United Arab Emirates

M

Mohammad Moayad Ahmad Alghaniem

School of Medicine, The University of Jordan, Amman, Jordan

A

Abdallah Abunamoos

School of Medicine, The University of Jordan, Amman, Jordan

S

Shamikha Cheema

King Edward Medical University, Lahore, Pakistan

S

S.M Washaqul Arfin

Ziauddin University, Karachi, Pakistan

A

Ayeza Nawaz

King Edward Medical University, Lahore , Pakistan

P

Pragnesh Kalyandrug

Trinity Medical Sciences University School of Medicine, Ribishi, Saint Vincent and the Grenadines

N

Nana Sardarova

Henry Ford Health System, Warren, MI

M

Mohammed Barawi

Henry Ford St John Hospital, Detroit, MI

K

Kelly Manahan

Trinity Medical Sciences University School of Medicine, Ribishi, Saint Vincent and the Grenadines

J

John Geisler

Trinity Medical Sciences University School of Medicine, Ribishi, Saint Vincent and the Grenadines